(Q33924340)

30 July 2017

Zaleplon and triazolam: drug discrimination, plasma levels, and self-administration in baboons (English)

1 reference

30 July 2017

1 reference

N A Ator

1

1 reference

PubMed ID

11064184

30 July 2017

language of work or name

1 reference

1 December 2000

1 reference

Drug and Alcohol Dependence

30 July 2017

1 reference

30 July 2017

61

1 reference

30 July 2017

1

1 reference

30 July 2017

55-68

1 reference

Drug discrimination analysis of endogenous neuroactive steroids in rats.

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2800%2900123-X

7 January 2021

Differential generalization to pentobarbital in rats trained to discriminate lorazepam, chlordiazepoxide, diazepam, or triazolam.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2800%2900123-X

7 January 2021

Differentiating benzodiazepine- and barbiturate-like discriminative stimulus effects of lorazepam, diazepam, pentobarbital, imidazenil and zaleplon in two- versus three-lever procedures.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2800%2900123-X

7 January 2021

Zaleplon and triazolam physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2800%2900123-X

7 January 2021

A placebo-controlled evaluation of single, escalating doses of CL 284,846, a non-benzodiazepine hypnotic.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2800%2900123-X

7 January 2021

Behavioural pharmacology of food, water and salt intake in relation to drug actions at benzodiazepine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2800%2900123-X

7 January 2021

Pharmacokinetics and pharmacodynamics of triazolam after two intermittent doses in obese and normal-weight men.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2800%2900123-X

7 January 2021

Discriminative stimulus properties of CL218872 and chlordiazepoxide in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2800%2900123-X

7 January 2021

Pharmacokinetics of the newer benzodiazepines

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2800%2900123-X

7 January 2021

Pharmacokinetics and anticonvulsant effect of a new hypnotic, CL 284,846, in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2800%2900123-X

7 January 2021

Self-injection of barbiturates, benzodiazepines and other sedative-anxiolytics in baboons

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2800%2900123-X

7 January 2021

Resolution of two biochemically and pharmacologically distinct benzodiazepine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2800%2900123-X

7 January 2021

Triazolam pharmacokinetics after intravenous, oral, and sublingual administration

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2800%2900123-X

7 January 2021

Zolpidem. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2800%2900123-X

7 January 2021

A tethering system for intravenous and intragastric drug administration in the baboon.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2800%2900123-X

7 January 2021

Zaleplon pharmacokinetics and absolute bioavailability

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2800%2900123-X

7 January 2021

Zaleplon and triazolam in humans: acute behavioral effects and abuse potential

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2800%2900123-X

7 January 2021

Discriminative stimulus effects of omega (BZ) receptor ligands: correlation with in vivo inhibition of [3H]-flumazenil binding in different regions of the rat central nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2800%2900123-X

7 January 2021

Comparison of the pharmacological profiles of the hypnotic drugs, zaleplon and zolpidem

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2800%2900123-X

7 January 2021

The discriminative stimulus properties of zolpidem, a novel imidazopyridine hypnotic.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2800%2900123-X

7 January 2021

Discriminative stimulus effects of alpidem, a new imidazopyridine anxiolytic

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2800%2900123-X

7 January 2021

A note on the measurement of conditional discrimination

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2800%2900123-X

7 January 2021

Evaluation of the discriminative stimulus effects of the novel sedative-hypnotic CL 284,846

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2800%2900123-X

7 January 2021

Beyond benzodiazepines: alternative pharmacologic agents for the treatment of insomnia

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2800%2900123-X

7 January 2021

Novel benzodiazepine receptor ligands: palatable food intake following zolpidem, CGS 17867A, or Ro23-0364, in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2800%2900123-X

7 January 2021

10.1016/S0376-8716(00)00123-X

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

11064184